Lipid Market Report 2026

The lipid market size has grown strongly in recent years. It will grow from $18.69 billion in 2025 to $20.32 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growing consumption of processed foods, expansion of cosmetic and personal care industries, rising pharmaceutical formulation advancements, increased use of dietary supplements, availability of diverse lipid sources.

The lipid market size is expected to see strong growth in the next few years. It will grow to $28.52 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing focus on bio-based and sustainable lipids, rising demand for nano-enabled lipid applications, expansion of pharmaceutical lipid carriers, growing consumer interest in functional foods, increasing investment in lipid processing technologies. Major trends in the forecast period include increasing demand for functional and nutritional lipids, rising use of lipids in cosmetic formulations, growing application of lipids in drug delivery systems, expansion of lipid use in food fortification, enhanced focus on lipid purity and stability.

The increasing prevalence of chronic diseases is expected to propel the growth of the lipid market in the coming years. Chronic diseases refer to long-term, non-communicable conditions such as cardiovascular diseases, diabetes, cancer, and neurological disorders that place a sustained burden on global healthcare systems. Lipids play a vital role in managing and preventing these conditions due to their ability to reduce inflammation, support cardiovascular function, protect brain health, and strengthen immune responses. As awareness of preventive healthcare and therapeutic nutrition rises, the demand for lipid-based solutions continues to grow. For instance, in July 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government health statistics agency, chronic conditions accounted for 78% of the total fatal disease burden in the country, marking an increase compared with previous years. Therefore, the rising prevalence of chronic diseases is significantly driving the growth of the lipid market.

Leading companies in the lipid market are concentrating on developing innovations, such as scalable mixing technology, which reduces risks as developers move from laboratory experiments to clinical applications. Scalable mixing technology in lipid formulation allows for the efficient and uniform blending of lipid-based ingredients across different production scales, ensuring consistency and quality in pharmaceutical formulations. For example, in July 2023, Cytiva, a UK-based biotechnology company, introduced the NanoAssemblr System to support end-to-end clinical and commercial manufacturing of lipid nanoparticle (LNP) medicines. This innovative formulation system employs scalable mixing technology to enable the seamless development of lipid nanoparticle medicines, from clinical trials to large-scale production. It features a single-use fluid path that minimizes the risk of cross-contamination and facilitates efficient batch changeovers, speeding up the time to market. Designed for comprehensive workflows, it enhances reproducibility and scalability, making it ideal for advancing nanoparticle-based therapies in fields such as gene therapy and oncology.

In October 2024, KD Pharma Group, a pharmaceutical manufacturing company based in Switzerland, acquired the Marine Lipids business from DSM-Firmenich for an undisclosed amount. This acquisition is intended to broaden KD Pharma Group's capabilities in the marine lipids market. By acquiring DSM-Firmenich’s Marine Lipids business, KD Pharma can enhance its portfolio of omega-3 products and solidify its position in the nutraceutical and pharmaceutical sectors. DSM-Firmenich is a nutrition, health, and sustainable living company located in the Netherlands.

Major companies operating in the lipid market are Aveda Corporation, Burt’s Bees Inc., The Estée Lauder Companies Inc., Bare Escentuals Beauty Inc., Arbonne International LLC, The Body Shop International PLC, Yves Rocher SA, L'Oréal S.A., Beiersdorf AG, Neutrogena Corporation, L'Occitane International S.A., Eminence Organic Skincare Inc., Natura Cosméticos S.A., Weleda AG, Hindustan Unilever Limited (HUL), Shanghai Pechoin Daily Chemical Co Ltd., Shea Terra Organics LLC, The Hain Celestial Group Inc., Amway Corporation, Fancl Corporation, DHC Corporation, Archer Daniels Midland Company, Koninklijke DSM N.V., Kerry Group PLC, Cargill Corporation, Nordic Naturals Inc., Omega Protein Corporation, Clover Corporation Limited, Solutex Corp., BASF SE, Croda International PLC, FMC Corporation, Stepan Company, NOF Corporation, Merck Millipore Limited.

Asia-Pacific was the largest region in the lipid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the lipid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The lipid market consists of sales of fats, oils, hormones, and waxes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.